OTC : BCLI

Brainstorm Cell Therapeutics Inc. — Earnings Estimates

$0.79 USD

$0.0 (0.31%)

Volume
5.38K
Average Volume
16.89K
Market Capitalization
$8.72M
P/E Ratio
-0.84
Dividend Yield
0.00%
Price Target
Year High
$1.69
Year Low
$0.46
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.02

Annual earnings financials

BCLI financial data with annual/quarterly toggle

BCLI GAAP EPS - Annual & Quarterly

BCLI Sales Revenue - Annual & Quarterly

BCLI Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

BCLI Estimated and Actual Revenue by Quarter
BCLI Estimated and Actual EPS by Quarter
BCLI Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-12-31 0 - - - - - -
2026-09-30 0 - - - - - -
2026-06-30 0 - - - - - -
2026-03-31 0 - - - - - -
2025-12-31 0 - - - - - -
2025-09-30 0 - - - - - -
BCLI Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-12-31 0 -2.43M -2.43M -2.43M - - -
2026-09-30 0 -2.32M -2.32M -2.32M - - -
2026-06-30 0 -3.2M -3.2M -3.2M - - -
2026-03-31 0 -3.97M -3.97M -3.97M - - -
2025-12-31 0 -2.6M -2.6M -2.6M - - -
2025-09-30 0 -4.07M -4.07M -4.07M - - -
BCLI Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-12-31 0 - - - 1 -0.22 -0.22 -0.22
2026-09-30 0 - - - 1 -0.21 -0.21 -0.21
2026-06-30 0 - - - 1 -0.29 -0.29 -0.29
2026-03-31 0 - - - 1 -0.36 -0.36 -0.36
2025-12-31 0 - - - 1 -0.28 -0.28 -0.28
2025-09-30 0 - - - 1 -0.37 -0.37 -0.37